Mixed cryoglobulinemia and thyroid autoimmune disorders.

Area of Science:

• Endocrinology
• Hepatology
• Immunology

Background:

• Hepatitis C virus (HCV) infection is linked to various autoimmune conditions.
• Mixed cryoglobulinemia (MC) is a known complication of chronic HCV infection.
• The association between MC+HCV and thyroid disorders requires further investigation.

Purpose of the Study:

• To investigate the prevalence of thyroid autoimmunity and dysfunction in patients with MC+HCV.
• To compare thyroid disorder rates in MC+HCV patients versus HCV-negative controls.
• To assess the incidence of papillary thyroid cancer in MC+HCV patients.

Main Methods:

• Comparative analysis of thyroid autoantibodies (AbTPO, AbTg) and thyroid function tests.
• Ultrasonographical assessment of thyroid morphology.
• Epidemiological comparison of thyroid cancer incidence.

Main Results:

• MC+HCV patients exhibited significantly higher levels of anti-thyroperoxidase autoantibody (AbTPO) and/or anti-thyroglobulin autoantibody (AbTg).
• Humoral and ultrasonographical signs of thyroid autoimmunity were present in 35% of MC+HCV patients.
• Subclinical hypothyroidism affected 11% of MC+HCV patients, and papillary thyroid cancer prevalence was elevated, especially in those with autoimmune thyroiditis.

Conclusions:

• HCV-associated mixed cryoglobulinemia is associated with a higher frequency of thyroid autoimmunity and subclinical hypothyroidism.
• Increased prevalence of papillary thyroid cancer in MC+HCV patients warrants attention.
• Routine thyroid function monitoring is recommended for patients with MC+HCV.